Sleeve lobectomy in patients with non-small-cell lung cancer: a report from the European Society of Thoracic Surgery database 2021
- 3 November 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 62 (6)
Abstract
OBJECTIVES: For centrally located lung tumours, sleeve lobectomy is preferred over pneumectomy. We report on the surgical practices and perioperative outcomes of sleeve resections based on data from the European Society of Thoracic Surgeons database. METHODS: We retrieved data of patients undergoing sleeve lobectomy or bilobectomy from 2007 to 2021. We evaluated baseline characteristics, surgical approach, neoadjuvant treatments, morbidity and postoperative outcomes of open and video-assisted thoracoscopic surgery (VATS) procedures. RESULTS: In total, 1652 patients (median age: 63 years; females/males: 446/1206) underwent sleeve lobectomy (n = 1536) or bilobectomy (n = 116) by open thoracotomy (n = 1491; 90.2%) or VATS (n = 161; 9.8%) with a thoracotomy conversion rate of 21.1% (n = 34); 398 (24.1%) patients received neoadjuvant treatment. Overall morbidity and 30-day mortality were 40.6% and 2.2%, respectively. Bronchial anastomotic complications occurred in 29 patients (1.8%) with conservative treatment in 6 cases (20.7%) and operative management in 23 (79.3%). On multivariable analysis, factors related to the elevated risk of cardiopulmonary complications were body mass index < 20 [odds ratio (OR): 2.26; P < 0.001] and bilobectomy (OR : 2.28, P < 0.001). Age <60 years (OR: 0.71, P = 0.013), female sex (OR: 0.54, P < 0.001) and VATS (0.64, P < 0.001) were associated with decreased risk. Neoadjuvant treatment was not associated with increased risks of cardiopulmonary complications (OR: 1.05; P = 0.664). Compared to open thoracotomy, VATS was associated with significantly decreased overall morbidity (30.4% vs 41.7%, P = 0.006) and length of stay (median: 5 days vs 8 days; P < 0.001). CONCLUSIONS: Sleeve lobectomies can be safely performed after neoadjuvant treatment. The VATS approach fosters shorter length of stay and decreased morbidity.Keywords
This publication has 29 references indexed in Scilit:
- Task-independent metrics to assess the data quality of medical registries using the European Society of Thoracic Surgeons (ESTS) DatabaseEuropean Journal of Cardio-Thoracic Surgery, 2011
- Is a sleeve lobectomy significantly better than a pneumonectomy?Interactive CardioVascular and Thoracic Surgery, 2010
- Sleeve Lobectomy as an Alternative Procedure to Pneumonectomy for Non-small Cell Lung CancerJournal of Thoracic Oncology, 2010
- Bilobectomy for non–small cell lung cancer: A search for clinical factors that may affect perioperative morbidity and long-term survivalThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Induction Chemotherapy Before Sleeve Lobectomy for Lung Cancer: Immediate and Long-Term ResultsThe Annals of Thoracic Surgery, 2009
- A quarter of a century experience with sleeve lobectomy for non-small cell lung cancer☆European Journal of Cardio-Thoracic Surgery, 2008
- Does sleeve lobectomy concomitant with or without pulmonary artery reconstruction (double sleeve) have favorable results for non-small cell lung cancer compared with pneumonectomy? A meta-analysisEuropean Journal of Cardio-Thoracic Surgery, 2007
- Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2007
- Low Morbidity and Mortality for Bronchoplastic Procedures With and Without Induction TherapyThe Annals of Thoracic Surgery, 2005
- Effects of preoperative chemotherapy and radiation therapy on human bronchial blood flowThe Journal of Thoracic and Cardiovascular Surgery, 2000